![](/img/cover-not-exists.png)
Phase I and pharmacokinetic study of 3′-C-ethynylcytidine (TAS-106), an inhibitor of RNA polymerase I, II and III,in patients with advanced solid malignancies
Lisa A. Hammond-Thelin, Melanie B. Thomas, Michiko Iwasaki, James L. Abbruzzese, Yvonne Lassere, Christina A. Meyers, Paulo Hoff, Johann de Bono, Jody Norris, Hitoshi Matsushita, Akira Mita, Eric K. RVolume:
30
Language:
english
Pages:
11
DOI:
10.1007/s10637-010-9535-y
Date:
February, 2012
File:
PDF, 237 KB
english, 2012